Fatty liver may directly mediate CAD in metabolic syndrome

January 23, 2013
Fatty liver may directly mediate CAD in metabolic syndrome
Men and women with fatty liver are more likely to have metabolic syndrome with type 2 diabetes, and women with fatty liver are more likely to have metabolic syndrome with subclinical atherosclerosis, according to research published online Dec. 18 in Diabetes Care.

(HealthDay)—Men and women with fatty liver are more likely to have metabolic syndrome (MetS) with type 2 diabetes, and women with fatty liver are more likely to have MetS with subclinical atherosclerosis, according to research published online Dec. 18 in Diabetes Care.

Juan G. Juárez-Rojas, Ph.D., of the National Institute of Cardiology in Mexico City, and colleagues conducted a study involving 765 people (52 percent women) without clinical atherosclerosis to study the role that fatty liver plays in the association of MetS with type 2 diabetes and (CAC). Fatty liver and CAC were determined using computed tomography.

The researchers found that fatty liver increased the association of MetS with type 2 diabetes in both women and men. Women and men with fatty liver were, respectively, 10.6- and 12.1-fold more likely to have MetS with . Additionally, women with fatty liver were 2.34-fold more likely to have MetS with CAC.

"Our study shows that isolated MetS is not independently associated with the presence of CAD. Consistent with findings of other studies, the prevalence of positive CAC was higher in men than in women," the authors write. "However, we found that fatty liver significantly favored the association of MetS with CAC only in women. Therefore, these results support the hypothesis that fatty liver may be not only a marker but even a direct mediator of atherosclerosis in women with MetS."

Explore further: Frequent moderate drinking of alcohol is associated with a lower risk of fatty liver disease

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Metabolic syndrome linked to arterial stiffness in CKD

June 4, 2012

(HealthDay) -- For patients with chronic kidney disease (CKD), those with metabolic syndrome (MetS) have increased arterial stiffness but no increase in endothelial dysfunction, compared to those without MetS, according to ...

Recommended for you

Low-carb diet may aid your metabolism

December 2, 2016

(HealthDay)—Eating low-carbohydrate meals may lead to healthy changes in a woman's metabolism that don't occur when consuming higher-carbohydrate meals, a small study suggests.

Research shows nerve growth protein controls blood sugar

November 14, 2016

Research led by a Johns Hopkins University biologist demonstrates the workings of a biochemical pathway that helps control glucose in the bloodstream, a development that could potentially lead to treatments for diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.